Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2400251	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2024-04-20		Innovent Biologics (Suzhou) Co Ltd			view
CXSS2400038	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2024-04-08		Innovent Biologics (Suzhou) Co Ltd			view
CXSB2300093	信迪利单抗注射液	sintilimab	Injection	Biological Products(原1)	Supplementary Application	2023-08-29		Innovent Biologics (Suzhou) Co Ltd			view
CXSL2300120	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2023-02-11		Innovent Biologics (Suzhou) Co Ltd			view
CYSB2200009	信迪利单抗注射液	sintilimab	Injection	Biological Products(原1)	Supplementary Application	2022-01-10		Innovent Biologics (Suzhou) Co Ltd			view
CXSS2101085	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2021-12-24		Innovent Biologics (Suzhou) Co Ltd			view
CXSB2101067	信迪利单抗注射液	sintilimab	Injection	Biological Products(原1)	Supplementary Application	2021-12-20		Innovent Biologics (Suzhou) Co Ltd			view
CXSS2101045	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2021-11-04		Innovent Biologics (Suzhou) Co Ltd			view
CYSB2101226	信迪利单抗注射液	sintilimab	Injection	Biological Products(1)	Supplementary Application	2021-10-19		Innovent Biologics (Suzhou) Co Ltd			view
CXSS2101031	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2021-09-22		Innovent Biologics (Suzhou) Co Ltd			view
CYSB2101178	信迪利单抗注射液	sintilimab	Injection	Biological Products(原1)	Supplementary Application	2021-09-06		Innovent Biologics (Suzhou) Co Ltd			view
CXSL2101074	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2021-05-14		Innovent Biologics (Suzhou) Co Ltd			view
CXSL2101032	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2021-04-23		Innovent Biologics (Suzhou) Co Ltd			view
CXSS2100009	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2021-01-13	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2021-01-12	view
CXSS2100007	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2021-01-13	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2021-11-05	view
CXSB2100002	信迪利单抗注射液	sintilimab	Injection	Biological Products(原1)	Supplementary Application	2021-01-06	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2021-09-02	view
CXSS2000043	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2020-08-20	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-19	view
CXSL2000234	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2020-08-12	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-11	view
CXSL2000232	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2020-08-12	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-11	view
CXSL2000223	信迪利单抗注射液	sintilimab	Injection	Biological Products(2.2)	New Drug Application	2020-08-04	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-03	view